After rolling out the Pfizer-BioNtech vaccine for coronavirus, Britain is hoping the approval for the Oxford-AstraZeneca’s shot will be given within a matter of days, David Prior, Chair of UK’s National Health Service said on Saturday.
“Next three months are going to be extremely difficult. Our hopes are pinned on the vaccine…We are hoping it will be approved within a matter of days.,” Prior said.
Speaking in the FICCI’s annual general meeting, Prior said that there has been a silver lining in the pandemic which has brought forth a whole new brand of research and development.
He said the current crisis has shown countries how we are totally unprepared for the pandemic of this kind. On the other hand, it has also triggered extraordinary innovation.
“We must win the public confidence in the efficacy and safety of the vaccine. This is why the regulatory process has to be independent.”
He also said that all around the world the health care systems have been struggling with the pandemic and it is not going to be manageable in the future.
“There has to be a fundamental change. and healthcare has to be more personalised. Going forward this revolution will be enabled by digitisation”.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.